Brian A Leuthner Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Brian A Leuthner.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian A Leuthner. Brian A Leuthner is Chief Operating Officer in ONCOSEC MEDICAL Inc ($ONCS) and Chief Executive Officer in Edge Therapeutics, Inc. ($EDGE) and President and CEO in Edge Therapeutics, Inc. ($EDGE).
Latest Insider Trading Transactions of Brian A Leuthner
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 17 2021 | ONCS | ONCOSEC MEDICAL In ... | Leuthner Brian A | Chief Operating Off ... | Option Exercise | A | 7.45 | 150,000 | 1,117,500 | 150,000 | |
Mar 18 2019 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | M | 0.00 | 169,032 | 0 | 0 | |
Mar 18 2019 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Buy | M | 0.00 | 169,032 | 0 | 239,268 | 70.2 K to 239.3 K (+240.66 %) |
Aug 15 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | A | 0.00 | 169,032 | 0 | 169,032 | |
Jun 20 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | A | 1.10 | 338,068 | 371,875 | 338,068 | |
Mar 05 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | A | 14.98 | 280,000 | 4,194,400 | 280,000 | |
Mar 05 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 15.08 | 2,500 | 37,700 | 70,236 | 72.7 K to 70.2 K (-3.44 %) |
Mar 05 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 14.81 | 2,500 | 37,025 | 72,736 | 75.2 K to 72.7 K (-3.32 %) |
Feb 23 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 15.37 | 2,500 | 38,425 | 75,236 | 77.7 K to 75.2 K (-3.22 %) |
Feb 23 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 15.47 | 2,500 | 38,675 | 77,736 | 80.2 K to 77.7 K (-3.12 %) |
Feb 02 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 12.96 | 2,500 | 32,400 | 80,236 | 82.7 K to 80.2 K (-3.02 %) |
Feb 02 2018 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 13.14 | 2,500 | 32,850 | 82,736 | 85.2 K to 82.7 K (-2.93 %) |
Dec 05 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.68 | 2,500 | 24,200 | 90,236 | 92.7 K to 90.2 K (-2.70 %) |
Dec 05 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.97 | 2,500 | 24,925 | 92,736 | 95.2 K to 92.7 K (-2.63 %) |
Dec 05 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.92 | 2,500 | 24,800 | 95,236 | 97.7 K to 95.2 K (-2.56 %) |
Nov 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.86 | 2,500 | 27,150 | 97,736 | 100.2 K to 97.7 K (-2.49 %) |
Nov 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.94 | 2,500 | 27,350 | 100,236 | 102.7 K to 100.2 K (-2.43 %) |
Nov 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.92 | 2,500 | 27,300 | 102,736 | 105.2 K to 102.7 K (-2.38 %) |
Oct 04 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 11.14 | 2,500 | 27,850 | 105,236 | 107.7 K to 105.2 K (-2.32 %) |
Oct 04 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.93 | 2,500 | 27,325 | 107,736 | 110.2 K to 107.7 K (-2.27 %) |
Oct 04 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.81 | 2,500 | 27,025 | 110,236 | 112.7 K to 110.2 K (-2.22 %) |
Sep 06 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.31 | 2,500 | 25,775 | 112,736 | 115.2 K to 112.7 K (-2.17 %) |
Sep 06 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.94 | 2,500 | 24,850 | 115,236 | 117.7 K to 115.2 K (-2.12 %) |
Sep 06 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.37 | 2,500 | 25,925 | 117,736 | 120.2 K to 117.7 K (-2.08 %) |
Aug 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.40 | 2,500 | 26,000 | 120,236 | 122.7 K to 120.2 K (-2.04 %) |
Aug 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.53 | 2,500 | 26,325 | 122,736 | 125.2 K to 122.7 K (-2.00 %) |
Aug 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.65 | 2,500 | 26,625 | 125,236 | 127.7 K to 125.2 K (-1.96 %) |
Jul 06 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.08 | 2,500 | 25,200 | 127,736 | 130.2 K to 127.7 K (-1.92 %) |
Jul 06 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.21 | 2,500 | 25,525 | 130,236 | 132.7 K to 130.2 K (-1.88 %) |
Jul 06 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.27 | 2,500 | 25,675 | 132,736 | 135.2 K to 132.7 K (-1.85 %) |
May 09 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 11.10 | 100 | 1,110 | 135,236 | 135.3 K to 135.2 K (-0.07 %) |
Mar 15 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | A | 8.86 | 267,500 | 2,370,050 | 267,500 | |
Feb 08 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.52 | 1,500 | 14,280 | 245,479 | 247 K to 245.5 K (-0.61 %) |
Feb 07 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.52 | 1,500 | 14,280 | 246,979 | 248.5 K to 247 K (-0.60 %) |
Feb 07 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.69 | 1,500 | 14,535 | 248,479 | 250 K to 248.5 K (-0.60 %) |
Feb 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.61 | 1,500 | 14,415 | 249,979 | 251.5 K to 250 K (-0.60 %) |
Feb 03 2017 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.38 | 1,500 | 14,070 | 251,479 | 253 K to 251.5 K (-0.59 %) |
Dec 02 2016 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 11.60 | 7,500 | 87,000 | 252,979 | 260.5 K to 253 K (-2.88 %) |
Oct 04 2016 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 10.25 | 7,500 | 76,844 | 260,479 | 268 K to 260.5 K (-2.80 %) |
Aug 02 2016 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.54 | 7,500 | 71,582 | 267,979 | 275.5 K to 268 K (-2.72 %) |
Aug 02 2016 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Sell | S | 9.54 | 7,500 | 71,582 | 267,979 | 275.5 K to 268 K (-2.72 %) |
Feb 18 2016 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | President and CEO | Option Exercise | A | 6.99 | 230,000 | 1,607,700 | 230,000 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | Chief Executive Off ... | Option Exercise | C | 0.00 | 3,655 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | Chief Executive Off ... | Buy | J | 8.60 | 80 | 688 | 550,958 | 550.9 K to 551 K (+0.01 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Leuthner Brian A | Chief Executive Off ... | Buy | C | 0.00 | 2,672 | 0 | 550,878 | 548.2 K to 550.9 K (+0.49 %) |
Page: 1